BIEI

Premier Biomedical Inc

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 9/28/2016
Contact Info
  • P.O. Box 25
  • Jackson Center, PA 16133

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001515740
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: NV, USA
Year of Inc. 2010
Employees Not Available
Company Officers/Contacts
Mitchell S. Felder Co-Founder
William A. Hartman President, CEO, Co-Founder
Patricio F. Reyes CTO
John Borza Vice President
Heidi H. Carl CFO, Corporate Secretary, Treasurer
Company Directors
Mitchell S. Felder Chairman
John Borza
Heidi H. Carl
William A. Hartman
Ronald LaBorde
Patricio F. Reyes
Jay Rosen
Service Providers
Accounting/Auditing Firm
M&K CPAS, PLLC
4100 North Sam Houston Pkwy W
Suite 200-B
Houston, TX, 77086
United States
 
Securities Counsel
Clyde Snow & Sessions OTCQX Sponsor
201 South Main
Suite 1300
Salt Lake City, UT, 84111
United States
 
Investor Relations Firm
UPTICK Newswire
10000 N 31st Ave
Suite C-105
Phoenix, AZ, 85051
United States
 
BIEI Security Details
Share Structure
Market Value1 $1,111,944 a/o Feb 17, 2017
Authorized Shares 1,000,000,000 a/o Sep 30, 2016
Outstanding Shares 226,927,427 a/o Nov 11, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 40,758,337 a/o Sep 30, 2015
Par Value 0.00001
Transfer Agent(s)
Interwest Transfer Co., Inc.
Shareholders
Shareholders of Record 130 a/o Mar 30, 2016
Short Selling Data
Short Interest 10,000 (-56.74%)
Jan 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security